カテゴリー： GlobalInfoResearch, 世界, 部品/材料

医薬品用活性炭の世界市場2022：石炭系活性炭、木質系活性炭、ヤシ系活性炭

◆英語タイトル：Global Activated Carbon for Pharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO1755 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：96 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

医薬品用活性炭市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用活性炭の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

医薬品用活性炭市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・石炭系活性炭、木質系活性炭、ヤシ系活性炭

用途別セグメントは次のように区分されます。
・原薬製造、完成品製造

世界の医薬品用活性炭市場の主要な市場プレーヤーは以下のとおりです。
・Kuraray、Jacobi Carbons、Fujian Yuanli Active Carbon、Cabot Norit、Ingevity Corporation、Haycarb、Datong Coal Jinding Activated Carbon、China Energy Investment Corporation、ADA-ES

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、医薬品用活性炭製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用活性炭メーカーの企業概要、2019年～2022年までの医薬品用活性炭の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用活性炭メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別医薬品用活性炭の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの医薬品用活性炭の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医薬品用活性炭市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用活性炭の産業チェーンを掲載しています。
・第13、14、15章では、医薬品用活性炭の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医薬品用活性炭の概要
- 種類別分析（2017年vs2021年vs2028年）：石炭系活性炭、木質系活性炭、ヤシ系活性炭
- 用途別分析（2017年vs2021年vs2028年）：原薬製造、完成品製造
- 世界の医薬品用活性炭市場規模・予測
- 世界の医薬品用活性炭生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Kuraray、Jacobi Carbons、Fujian Yuanli Active Carbon、Cabot Norit、Ingevity Corporation、Haycarb、Datong Coal Jinding Activated Carbon、China Energy Investment Corporation、ADA-ES
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：石炭系活性炭、木質系活性炭、ヤシ系活性炭
・用途別分析2017年-2028年：原薬製造、完成品製造
・医薬品用活性炭の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用活性炭のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用活性炭のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用活性炭の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用活性炭の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Activated Carbon for Pharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Activated Carbon for Pharmaceuticals market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. API Production accounting for % of the Activated Carbon for Pharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Coal-Based Activated Carbon segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Activated Carbon for Pharmaceuticals include Kuraray, Jacobi Carbons, Fujian Yuanli Active Carbon, Cabot Norit, and Ingevity Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Activated Carbon for Pharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Coal-Based Activated Carbon
Wood-Based Activated Carbon
Coconut-Based Activated Carbon
Market segment by Application can be divided into
API Production
Finished Drug Production
The key market players for global Activated Carbon for Pharmaceuticals market are listed below:
Kuraray
Jacobi Carbons
Fujian Yuanli Active Carbon
Cabot Norit
Ingevity Corporation
Haycarb
Datong Coal Jinding Activated Carbon
China Energy Investment Corporation
ADA-ES
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Activated Carbon for Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Activated Carbon for Pharmaceuticals, with price, sales, revenue and global market share of Activated Carbon for Pharmaceuticals from 2019 to 2022.
Chapter 3, the Activated Carbon for Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Activated Carbon for Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Activated Carbon for Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Activated Carbon for Pharmaceuticals.
Chapter 13, 14, and 15, to describe Activated Carbon for Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Activated Carbon for Pharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Activated Carbon for Pharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Coal-Based Activated Carbon
1.2.3 Wood-Based Activated Carbon
1.2.4 Coconut-Based Activated Carbon
1.3 Market Analysis by Application
1.3.1 Overview: Global Activated Carbon for Pharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 API Production
1.3.3 Finished Drug Production
1.4 Global Activated Carbon for Pharmaceuticals Market Size & Forecast
1.4.1 Global Activated Carbon for Pharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Activated Carbon for Pharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Activated Carbon for Pharmaceuticals Price (2017-2028)
1.5 Global Activated Carbon for Pharmaceuticals Production Capacity Analysis
1.5.1 Global Activated Carbon for Pharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Activated Carbon for Pharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Activated Carbon for Pharmaceuticals Market Drivers
1.6.2 Activated Carbon for Pharmaceuticals Market Restraints
1.6.3 Activated Carbon for Pharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Kuraray
2.1.1 Kuraray Details
2.1.2 Kuraray Major Business
2.1.3 Kuraray Activated Carbon for Pharmaceuticals Product and Services
2.1.4 Kuraray Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Jacobi Carbons
2.2.1 Jacobi Carbons Details
2.2.2 Jacobi Carbons Major Business
2.2.3 Jacobi Carbons Activated Carbon for Pharmaceuticals Product and Services
2.2.4 Jacobi Carbons Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fujian Yuanli Active Carbon
2.3.1 Fujian Yuanli Active Carbon Details
2.3.2 Fujian Yuanli Active Carbon Major Business
2.3.3 Fujian Yuanli Active Carbon Activated Carbon for Pharmaceuticals Product and Services
2.3.4 Fujian Yuanli Active Carbon Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cabot Norit
2.4.1 Cabot Norit Details
2.4.2 Cabot Norit Major Business
2.4.3 Cabot Norit Activated Carbon for Pharmaceuticals Product and Services
2.4.4 Cabot Norit Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ingevity Corporation
2.5.1 Ingevity Corporation Details
2.5.2 Ingevity Corporation Major Business
2.5.3 Ingevity Corporation Activated Carbon for Pharmaceuticals Product and Services
2.5.4 Ingevity Corporation Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Haycarb
2.6.1 Haycarb Details
2.6.2 Haycarb Major Business
2.6.3 Haycarb Activated Carbon for Pharmaceuticals Product and Services
2.6.4 Haycarb Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Datong Coal Jinding Activated Carbon
2.7.1 Datong Coal Jinding Activated Carbon Details
2.7.2 Datong Coal Jinding Activated Carbon Major Business
2.7.3 Datong Coal Jinding Activated Carbon Activated Carbon for Pharmaceuticals Product and Services
2.7.4 Datong Coal Jinding Activated Carbon Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 China Energy Investment Corporation
2.8.1 China Energy Investment Corporation Details
2.8.2 China Energy Investment Corporation Major Business
2.8.3 China Energy Investment Corporation Activated Carbon for Pharmaceuticals Product and Services
2.8.4 China Energy Investment Corporation Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ADA-ES
2.9.1 ADA-ES Details
2.9.2 ADA-ES Major Business
2.9.3 ADA-ES Activated Carbon for Pharmaceuticals Product and Services
2.9.4 ADA-ES Activated Carbon for Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Activated Carbon for Pharmaceuticals Breakdown Data by Manufacturer
3.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Activated Carbon for Pharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Activated Carbon for Pharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Activated Carbon for Pharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Activated Carbon for Pharmaceuticals Manufacturer Market Share in 2021
3.5 Global Activated Carbon for Pharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Activated Carbon for Pharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Activated Carbon for Pharmaceuticals Market Size by Region
4.1.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Activated Carbon for Pharmaceuticals Revenue by Region (2017-2028)
4.2 North America Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.3 Europe Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.5 South America Activated Carbon for Pharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Activated Carbon for Pharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Activated Carbon for Pharmaceuticals Revenue by Type (2017-2028)
5.3 Global Activated Carbon for Pharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Activated Carbon for Pharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Activated Carbon for Pharmaceuticals Revenue by Application (2017-2028)
6.3 Global Activated Carbon for Pharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
7.2 North America Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
7.3 North America Activated Carbon for Pharmaceuticals Market Size by Country
7.3.1 North America Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
8.2 Europe Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
8.3 Europe Activated Carbon for Pharmaceuticals Market Size by Country
8.3.1 Europe Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Activated Carbon for Pharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Activated Carbon for Pharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Activated Carbon for Pharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
10.2 South America Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
10.3 South America Activated Carbon for Pharmaceuticals Market Size by Country
10.3.1 South America Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Activated Carbon for Pharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Activated Carbon for Pharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Activated Carbon for Pharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Activated Carbon for Pharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Activated Carbon for Pharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Activated Carbon for Pharmaceuticals
12.3 Activated Carbon for Pharmaceuticals Production Process
12.4 Activated Carbon for Pharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Activated Carbon for Pharmaceuticals Typical Distributors
13.3 Activated Carbon for Pharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品用活性炭の世界市場2022：石炭系活性炭、木質系活性炭、ヤシ系活性炭(Global Activated Carbon for Pharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医薬品用活性炭の世界市場2022：石炭系活性炭、木質系活性炭、ヤシ系活性炭

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp